NeuroQuant

Cortechs Labs

NeuroQuant® aids the diagnosis and monitoring of neurodegenerative brain disorders with automated tools. NeuroQuant® is FDA 510(k) cleared, CE marked and South Korea, Australia, and Brazil, approved medical device software for quantitative analysis from MRI. It integrates with your existing PACS system. NeuroQuant provides volumetric measurements of brain structures and compares the volumes to a normative database adjusted for age, sex, and intracranial volume.
Product specifications Information source: Public
Last updated: Jan. 23, 2020
General
Product name NeuroQuant
Company Cortechs Labs
Subspeciality Neuro
Modality MR
Disease targeted neurodegenerative brain disorders
Key-features brain region quantification, normal comparison
Suggested use
Data characteristics
Population
Input
Input format
Output
Output format
Technology
Integration
Deployment
Trigger for analysis
Processing time
Certification
CE Certified, Class unknown
FDA 510(k) cleared, Class II
Market presence
On market since
Distribution channels
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model
Based on
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers